methylphenidate has been researched along with Pulmonary Sarcoidosis in 2 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fatigue is a common complaint in patients with sarcoidosis." | 6.73 | Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue. ( Baughman, RP; Harman, S; Lower, EE, 2008) |
| "Fatigue is a common complaint in patients with sarcoidosis." | 2.73 | Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue. ( Baughman, RP; Harman, S; Lower, EE, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tachibana, T | 1 |
| Iwai, K | 1 |
| Takemura, T | 1 |
| Lower, EE | 1 |
| Harman, S | 1 |
| Baughman, RP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Fatigue in Sarcoidosis - A Feasibility Study Investigating the Treatment of Fatigue in Stable Sarcoidosis Patients Using Methylphenidate[NCT02643732] | 30 participants (Anticipated) | Interventional | 2016-11-30 | Recruiting | |||
| Randomized, Double-Blind, Placebo-Controlled Study of Dexmethylphenidate Hydrochloride, (d-MPH) in the Treatment of Fatigue in Sarcoidosis Subjects.[NCT00361387] | Phase 4 | 12 participants (Anticipated) | Interventional | 2006-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for methylphenidate and Pulmonary Sarcoidosis
| Article | Year |
|---|---|
Sarcoidosis in the aged: review and management.
Topics: Age Factors; Aged; Aged, 80 and over; Bosentan; Humans; Incidence; Methylphenidate; Sarcoidosis, Pul | 2010 |
1 trial available for methylphenidate and Pulmonary Sarcoidosis
| Article | Year |
|---|---|
Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue.
Topics: Adult; Aged; Central Nervous System Stimulants; Cross-Over Studies; Dexmethylphenidate Hydrochloride | 2008 |
Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue.
Topics: Adult; Aged; Central Nervous System Stimulants; Cross-Over Studies; Dexmethylphenidate Hydrochloride | 2008 |
Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue.
Topics: Adult; Aged; Central Nervous System Stimulants; Cross-Over Studies; Dexmethylphenidate Hydrochloride | 2008 |
Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue.
Topics: Adult; Aged; Central Nervous System Stimulants; Cross-Over Studies; Dexmethylphenidate Hydrochloride | 2008 |